2025年美国临床肿瘤学会（ASCO）年会肝胆胰肿瘤研究热点与前沿动态

Highlights and cutting-edge advances in hepatobiliary and pancreatic cancer research at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025

摘要:

2025年美国临床肿瘤学会（ASCO）年会于2025年5月30日—6月3日在芝加哥召开。作为全球肿瘤学领域规模最大、最具影响力的学术盛会之一，ASCO年会汇聚众多世界一流的肿瘤学专家，聚焦于肝癌、胆管癌、胰腺癌等消化道肿瘤领域尚未满足的临床需求，呈现许多前沿的科研成果和治疗技术，为肝胆胰恶性肿瘤的诊疗提供重要的循证支持。本文基于ASCO 2025年会中肝胆胰肿瘤领域的前沿成果，探讨相关治疗领域的热点问题和未来发展方向。

Abstract:

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting was held in Chicago from May 30 to June 3, 2025. As one of the largest and most influential academic events in global oncology, the ASCO meeting brought together numerous world-class oncology experts. It focused on the unmet clinical needs in gastrointestinal malignancies such as hepatocellular carcinoma, cholangiocarcinoma, and pancreatic cancer, and presented a wealth of cutting-edge research findings and therapeutic innovations. These advances provide important evidence-based support for the diagnosis and treatment of hepatobiliary and pancreatic cancers. Based on the latest achievements presented at ASCO 2025, this article discusses the hot topics and future directions in the management of hepatobiliary and pancreatic tumors.